TGFK-09SD

Last updated
TGFK-09SD
Clinical data
Other namesTGFK09SD
Routes of
administration 		Oral [1]
Drug class Serotonin 5-HT1A receptor agonist
ATC code
  • None

TGFK-09SD, or TGFK09SD, is a serotonin 5-HT1A receptor agonist which is or was under development for the treatment of female sexual dysfunction but was never marketed. [1] [2] It is taken orally. [1] The drug was developed by Fabre-Kramer Pharmaceuticals. [1] As of January 2016, it is in phase 2 clinical trials. [1] There have been no further updates on the development of the drug since then. [1] The chemical structure of TGFK-09SD does not yet appear to have been disclosed. [1]

Contents

See also

References

  1. 1 2 3 4 5 6 7 "TGFK 09SD". AdisInsight. 8 January 2016. Retrieved 27 January 2026.
  2. ↑ "Details of the Drug-Related molecule(s) Interaction Atlas". DrugMAP. 1 April 2024. Retrieved 27 January 2026.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.